316 related articles for article (PubMed ID: 26694726)
1. Drug Transporters and Multiple Drug Resistance in Pediatric Solid Tumors.
Fruci D; Cho WC; Nobili V; Locatelli F; Alisi A
Curr Drug Metab; 2016; 17(4):308-16. PubMed ID: 26694726
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
Pérez-Tomás R
Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
[TBL] [Abstract][Full Text] [Related]
3. [Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].
Wei N; Sun H; Liu GT
Yao Xue Xue Bao; 2010 Oct; 45(10):1205-11. PubMed ID: 21348297
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
5. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
[TBL] [Abstract][Full Text] [Related]
6. Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration.
Krchniakova M; Skoda J; Neradil J; Chlapek P; Veselska R
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365759
[TBL] [Abstract][Full Text] [Related]
7. Reversing agents for ATP-binding cassette drug transporters.
Lee CH
Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930
[TBL] [Abstract][Full Text] [Related]
8. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.
Mohammad IS; He W; Yin L
Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043
[TBL] [Abstract][Full Text] [Related]
9. The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy.
Wu CP; Hsieh CH; Wu YS
Mol Pharm; 2011 Dec; 8(6):1996-2011. PubMed ID: 21770407
[TBL] [Abstract][Full Text] [Related]
10. Revisiting the ABCs of multidrug resistance in cancer chemotherapy.
Tiwari AK; Sodani K; Dai CL; Ashby CR; Chen ZS
Curr Pharm Biotechnol; 2011 Apr; 12(4):570-94. PubMed ID: 21118094
[TBL] [Abstract][Full Text] [Related]
11. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
12. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.
McIntosh K; Balch C; Tiwari AK
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):633-44. PubMed ID: 27116192
[TBL] [Abstract][Full Text] [Related]
13. Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism.
Joyce H; McCann A; Clynes M; Larkin A
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):795-809. PubMed ID: 25836015
[TBL] [Abstract][Full Text] [Related]
14. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
[TBL] [Abstract][Full Text] [Related]
15. ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance.
Fan J; To KKW; Chen ZS; Fu L
Drug Resist Updat; 2023 Jan; 66():100905. PubMed ID: 36463807
[TBL] [Abstract][Full Text] [Related]
16. Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies.
Li W; Zhang H; Assaraf YG; Zhao K; Xu X; Xie J; Yang DH; Chen ZS
Drug Resist Updat; 2016 Jul; 27():14-29. PubMed ID: 27449595
[TBL] [Abstract][Full Text] [Related]
17. Targeting multidrug resistance in cancer.
Szakács G; Paterson JK; Ludwig JA; Booth-Genthe C; Gottesman MM
Nat Rev Drug Discov; 2006 Mar; 5(3):219-34. PubMed ID: 16518375
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma.
Alisi A; Cho WC; Locatelli F; Fruci D
Int J Mol Sci; 2013 Dec; 14(12):24706-25. PubMed ID: 24351843
[TBL] [Abstract][Full Text] [Related]
19. The role of ABC transporters in clinical practice.
Leonard GD; Fojo T; Bates SE
Oncologist; 2003; 8(5):411-24. PubMed ID: 14530494
[TBL] [Abstract][Full Text] [Related]
20. Expression of proteins associated with therapy resistance in rhabdomyosarcoma and neuroblastoma tumour cells.
Pituch-Noworolska A; Zaremba M; Wieczorek A
Pol J Pathol; 2009; 60(4):168-73. PubMed ID: 20072950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]